News Articles

Industry to refocus and reinvest in US following potential medical device tax repeal, say CRO execs

06-Aug-2018 By Melissa Fassbender, Outsourcing-Pharma.com

Repeal of the hotly debated medical device tax would free up research and development resources and bring clinical trials back to the US, say CRO industry executives.

Link to Article